Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Krystal Biotech Inc
NASDAQ:KRYS
Krystal Biotech Inc
NASDAQ:KRYS
Price:
302.03
USD
0.59%
Market Closed
Market Cap:
$8.9B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Krystal Biotech Inc
NASDAQ:KRYS
|
US |
|
V
|
Victory Capital Holdings Inc
F:3PK
|
US |
|
Takihyo Co Ltd
TSE:9982
|
JP |
|
T
|
Trinity Watthana PCL
SET:TNITY
|
TH |
|
A
|
ADM Hamburg AG
F:OEL
|
DE |
|
K
|
Krystal Biotech Inc
SWB:4KB
|
US |
|
Magnitogorskiy Metallurgicheskiy Kombinat P.A.O.
MOEX:MAGN
|
RU |
|
K
|
Krystal Biotech Inc
F:4KB
|
US |
Wall St Price Targets
KRYS Price Forecast
Based on 14 analysts
Based on 14 analysts
+35% Upside
from
$302.03
today
Krystal Biotech Inc (KRYS)’s 12-month stock price forecast through November 2027 has a consensus target of $408, implying 35% upside. The forecast is based on price targets from 14 Wall Street analysts.
KRYS Analyst Rating
Based on 12 analysts
Based on 12 analysts
Analysts rate KRYS Strong buy, with 11 of 12 recommending Buy or Strong buy.
Krystal Biotech Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is KRYS's stock price target?
Price Target
408
USD
408
USD
According to Wall Street analysts, the average 1-year price target for KRYS is 408 USD with a low forecast of 286.84 USD and a high forecast of 497.7 USD.
What is the Revenue forecast for Krystal Biotech Inc?
Projected CAGR
22%
22%
The compound annual growth rate for Revenue over the next 8 years is 22%.
What is the Gross Profit forecast for Krystal Biotech Inc?
Projected CAGR
22%
22%
The compound annual growth rate for Gross Profit over the next 8 years is 22%.
What is the Operating Income forecast for Krystal Biotech Inc?
Projected CAGR
31%
31%
The compound annual growth rate for Operating Income over the next 8 years is 31%.
What is the Pre-Tax Income forecast for Krystal Biotech Inc?
Projected CAGR
44%
44%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 44%.
What is the Net Income forecast for Krystal Biotech Inc?
Projected CAGR
21%
21%
The compound annual growth rate for Net Income over the next 8 years is 21%.
